126 related articles for article (PubMed ID: 25669040)
1. [Case conference of hematological malignancies based on the morphology of blood cells: chairmen's introductory remarks].
Inaba T; Tohyama K
Rinsho Byori; 2014 Jul; 62(7):699-701. PubMed ID: 25669040
[TBL] [Abstract][Full Text] [Related]
2. [Case Conference of Hematological Malignancies Based on the Morphology of Blood Cells: Chairmen's Introductory Remarks].
Inaba T; Ikemoto T
Rinsho Byori; 2016 Nov; 64(11):1310-1312. PubMed ID: 30695313
[TBL] [Abstract][Full Text] [Related]
3. [Case conference of hematological diseases based on the morphology of blood cells: Chairman's introductory remarks].
Tohyama K
Rinsho Byori; 2013 Apr; 61(4):342-3. PubMed ID: 23855191
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
5. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic and hematological spontaneous remission in a case of acute myelogenous leukemia.
Fozza C; Bellizzi S; Bonfigli S; Campus PM; Dore F; Longinotti M
Eur J Haematol; 2004 Sep; 73(3):219-22. PubMed ID: 15287921
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR(negative), CD34(negative) hypergranular acute myeloid leukemia with trisomy 6 and del(5)(q22q33): case report and review of the literature.
Argiropoulos B; Clifford B; Crocker S; Sinclair-Bourque E; McCready E; McGowan-Jordan J; Johnston DL; Padmore R
J Pediatr Hematol Oncol; 2011 Oct; 33(7):e289-95. PubMed ID: 21768886
[TBL] [Abstract][Full Text] [Related]
8. [Development of novel laboratory technology--Chairmen's introductory remarks].
Maekawa M; Ando Y
Rinsho Byori; 2012 Jul; 60(7):627-9. PubMed ID: 22973721
[TBL] [Abstract][Full Text] [Related]
9. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic polyclonality in hematologic malignancies.
Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
[TBL] [Abstract][Full Text] [Related]
11. Jumping translocations in hematological malignancies: a cytogenetic study of five cases.
Manola KN; Georgakakos VN; Stavropoulou C; Spyridonidis A; Angelopoulou MK; Vlachadami I; Katsigiannis A; Roussou P; Pantelias GE; Sambani C
Cancer Genet Cytogenet; 2008 Dec; 187(2):85-94. PubMed ID: 19027489
[TBL] [Abstract][Full Text] [Related]
12. Patterns of hematological and non-hematological malignancies in bone marrow in a tertiary care hospital in Nepal--11 years study.
Ghartimagar D; Ghosh A; Narasimhan R; Talwar OP
Nepal Med Coll J; 2012 Sep; 14(3):187-92. PubMed ID: 24047012
[TBL] [Abstract][Full Text] [Related]
13. Association of the blood eosinophil count with hematological malignancies and mortality.
Andersen CL; Siersma VD; Hasselbalch HC; Vestergaard H; Mesa R; Felding P; Olivarius ND; Bjerrum OW
Am J Hematol; 2015 Mar; 90(3):225-9. PubMed ID: 25488524
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
16. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies.
Hock BD; McKenzie JL; Patton NW; Drayson M; Taylor K; Wakeman C; Kantarjian H; Giles F; Albitar M
Cancer; 2006 May; 106(10):2148-57. PubMed ID: 16598754
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies.
Miyagawa K; Hayashi Y; Fukuda T; Mitani K; Hirai H; Kamiya K
Genes Chromosomes Cancer; 1999 Jun; 25(2):176-83. PubMed ID: 10338002
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
Zhang LJ; Shin ES; Yu ZX; Li SB
Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
[TBL] [Abstract][Full Text] [Related]
20. [p53 and hematologic malignancies].
Preudhomme C; Fenaux P
Pathol Biol (Paris); 1997 Dec; 45(10):898-908. PubMed ID: 9769955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
